LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

SUPRIYA

NSEBSE
Supriya Lifescience Limited
Healthcare· Pharmaceuticals & Biotechnology· INE07RO01027· Scrip: 543434
ENहिन्दीગુજરાતીमराठी
६९७.००
1.25 (-0.18%)
1/5/2026, 3:28:57 pm
NSE
६९७.००
१.२५
-०.१८%
BSE
६९४.५०
५.०५
+०.००%
56262368474580705-0206-2708-2510-2312-1902-1804-2704-30
२४४ व्यापार दिन · 1Y कालावधी
आज
उघडणे७०३.००
उच्चांक७०३.३०
नीचांक६८३.५५
मागील बंद६९८.२५
व्हॉल्यूम१.०८L
मूल्य₹७.५Cr
L: 683.55H: 703.30
52 आठवडे
नीचांक५४५.५०
उच्चांक८३२.४०
५३% 52 आठवड्यांच्या श्रेणीत
माहिती
दर्शनी मूल्य₹२
सूचीबद्ध2021-12-28
ISININE07RO01027
SeriesA
BSE स्क्रिप543434

मुख्य निर्देशक

1D
-0.18%
1W
+5.11%
1M
+23.50%
3M
-3.70%
6M
-5.63%
मूल्यांकन
P/E (TTM)३२.१८
P/E (Qtr Ann.)२९.९४
P/Sales७.३३
वाढ (तिमाही)
PAT+1.37%
EPS+1.93%
नफाक्षमता
TTM EBITDA M.३८.२%

तिमाही वित्तीय

महसूल
EBITDA
PAT
EPS
0 Cr46 Cr93 Cr139 Cr186 Cr23-0323-0623-0923-1224-0324-0624-0924-124.83.53.03.74.65.55.75.8
तिमाहीमहसूलExpensesEBITDAPBTPATEPS
2024-12-31186 Cr125 Cr68 Cr63 Cr47 Cr5.82
2024-09-30166 Cr107 Cr67 Cr62 Cr46 Cr5.71
2024-06-30161 Cr103 Cr64 Cr60 Cr45 Cr5.54
2024-03-31158 Cr107 Cr57 Cr53 Cr37 Cr4.59
2023-12-31140 Cr103 Cr44 Cr40 Cr30 Cr3.70
2023-09-30140 Cr113 Cr34 Cr30 Cr24 Cr2.97
2023-06-30132 Cr92 Cr47 Cr43 Cr29 Cr3.54
2023-03-31142 Cr91 Cr56 Cr53 Cr38 Cr4.75

शेअरहोल्डिंग नमुना

सध्याचे2026-03-31
68.3%प्रवर्तक
प्रवर्तक68.3%
FII5.2%
DII5.7%
सार्वजनिक31.7%
प्रवर्तक होल्डिंग ट्रेंड
68.3%24-0668.3%24-0968.3%24-1268.3%25-0368.3%25-0968.3%25-1268.3%26-03

कॉर्पोरेट कार्यवाही

एक्स-तारीखप्रकारउद्देश
2025-09-04DividendDividend - Re 1 Per Share
2024-09-20DividendAnnual General Meeting/Dividend - Rs 0.80 Per Share
2023-09-15DividendAnnual General Meeting/Dividend - Re 0.60 Per Share
2022-09-01DividendAnnual General Meeting/Dividend - Re 0.60 Per Share

उत्पन्न विवरण

Supriya Lifescience Limited has informed the Exchange about Link of Recording of the Earnings Call f...
13 Nov 2025NSE1K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
12 Nov 2025NSE29K chars
Read →
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201...
9 Nov 2025NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
13 Aug 2025NSE28K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
27 May 2025NSE26K chars
Read →
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, the details of the Analyst/Investor Meetin...
17 Mar 2025NSE3K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
24 Jan 2025NSE28K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
7 Nov 2023NSE29K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
3 Aug 2023NSE25K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
27 May 2023NSE29K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Investor Presentation
14 Feb 2023NSE27K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...
17 Nov 2022NSE40K chars
Read →
In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure ...
11 Nov 2022NSE2K chars
Read →
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,...
11 Nov 2022NSE30K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Inves...
3 Nov 2022NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Inves...
30 Aug 2022NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Inves...
25 Aug 2022NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Inves...
24 Aug 2022NSE2K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...
23 Aug 2022NSE56K chars
Read →
Supriya Lifescience Limited has informed the Exchange about Recording of Analysts/Institutional Inve...
16 Aug 2022NSE2K chars
Read →

किंमत इतिहास

तारीखउघडणेउच्चांकनीचांकबंदव्हॉल्यूम
2026-04-30७०३.००७०३.३०६८३.५५६९४.९०१.०८L
2026-04-29७०४.७०७०७.८०६९५.००६९८.२५१.२२L
2026-04-28७०९.००७१७.४५७००.००७०४.७०२.१५L
2026-04-27६६०.००७१०.००६५५.००७०४.४५१०.५७L
2026-04-24६६३.५०६६८.९०६३२.०५६४२.८५५.७८L
2026-04-23६५७.००६६९.००६५०.१०६६३.१०१.६६L
2026-04-22६२१.७५६६०.००६२०.००६५६.००४.०४L
2026-04-21६२४.७५६२९.९०६१८.००६२०.७५८५,२०७
2026-04-20६४७.००६५१.००६१५.१०६१९.८०२.२५L
2026-04-17६३५.००६६५.६०६१९.३५६३८.५०२.००L
2026-04-16६३८.४५६४४.९०६२५.३५६२८.३०९०,९४७
2026-04-15६४६.००६५३.२०६३१.३०६३५.३५१.११L
2026-04-13६१७.००६४२.४०६१७.००६३७.५५८४,८००
2026-04-10६३४.९५६४५.००६३१.६५६३८.७५५७,२४३
2026-04-09६२८.००६४०.१५६२४.६५६२८.५५७१,४६७
2026-04-08६४२.२५६४२.२५६२१.९०६३६.९५१.०१L
2026-04-07६१८.९०६१८.९०६०३.२०६१०.७०६२,८३४
2026-04-02५९०.१०६१५.००५८३.९५६१२.२०९६,९७४
2026-04-01५६९.९५६१३.०५५६९.९५६०१.००२.०९L
2026-03-27५९३.००६०९.७०५७९.६५५८७.५५२.६८L
2026-03-25५७४.८०६०५.९५५७४.१०५९२.६०२.२५L
2026-03-24५६२.३०५७९.००५४५.५०५६४.३५३.२९L
2026-03-20५८२.००५९२.५०५८२.००५८४.२०९५,७६५
2026-03-19५७६.००५८७.५०५७६.००५७९.९०१.४३L
2026-03-18५७६.००५९८.९०५७६.००५८९.२५१.६४L
2026-03-17५८०.००५९५.९५५७०.२०५७४.५०१.४०L
2026-03-16५७३.००५८८.००५६५.००५७३.८०१.७५L
2026-03-13५८९.६५६०५.००५७४.५५५७६.९०२.६३L
2026-03-12५९६.५५६०३.९०५८१.९०५८५.८०२.३०L
2026-03-11६१०.००६१४.००५९५.००५९६.५५७४,३८७

वारंवार विचारले जाणारे प्रश्न

बद्दल

1987 मध्ये स्थापन झालेली सुप्रिया लाइफसायन्स लिमिटेड ही मुंबईतील एक प्रमुख भारतीय जेनेरिक फार्मास्युटिकल कंपनी आहे, जी अँटीहिस्टामाइन्स, अँटी-ॲलॅरॅथिक उपचारांसह विविध उपचारात्मक क्षेत्रांसाठी मोठ्या प्रमाणात औषधे आणि सक्रिय फार्मास्युटिकल घटक (APIs) च्या संशोधन, विकास, उत्पादन आणि विक्रीमध्ये माहिर आहे. कंपनी एपीआय आणि फार्मास्युटिकल रसायनांवर लक्ष केंद्रित करून जागतिक फार्मास्युटिकल मार्केटची पूर्तता करते, जेनेरिक औषधांच्या पुरवठा साखळीत महत्त्वपूर्ण योगदान देते.

BOARD OF DIRECTORS